Recent positive lab confirmation of Smart mRNA functionality is a tremendous milestone for the Company. This marks a ...

Clinical studies suggest that the mRNA vaccine could aid in treating pancreatic cancer, one of the most lethal forms of ...

Clinical studies suggest that the mRNA vaccine may play a role in treating pancreatic cancer, identified as one of the most ...

A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease ...

The mRNA vaccine works by targeting genetic mutations found in pancreatic cancer, alerting the immune system to recognize and ...

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

The phase 1 trial results, published Feb. 19 in Nature, evaluated the personalized mRNA neoantigen vaccine autogene cevumeran in combination with surgery, immunotherapy drug atezolizumab and ...

There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target ...

A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

WASHINGTON, DC – Two Indian Americans, Yale Law School professor Natasha Sarin and surgical oncologist Dr. Vinod Balachandran ...